Jan Makela
CIK 1951803 · CEO, Imaging · last filed 2024-05-15
Jan Makela is a CEO, Imaging who has filed 11 SEC Form 4 insider transactions across 2 companies since 2023. The most recent filing, for GEHC, was dated Aug 12, 2024. Across all open-market trades the lifetime net is −$12.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
GEHC price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
CHICAGO, IL 60661
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GEHC | CEO, Imaging | 63,348 | $71.11 | $4.50M | -$12.60M | 8 | 2024-05-15 |
| GE HealthCare Technologies Inc. (GEHCV) Delisted | CEO, Imaging | 32 | — | — | $0 | 1 | 2023-01-05 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-08-12 | GEHC | Notice (144) | −33,096 | -$2.75M | EDGAR |
| 2024-05-15 | GEHC | Mixed | — | -$846.6K | EDGAR |
| 2024-05-13 | GEHC | Notice (144) | −87,182 | -$7.11M | EDGAR |
| 2024-03-05 | GEHC | Mixed | −11,271 | -$1.77M | EDGAR |
| 2023-12-29 | GEHC | Grant (A) | +17,348 | $0 | EDGAR |
| 2023-08-07 | GEHC | Tax (F) | −4,596 | -$350.2K | EDGAR |
| 2023-07-05 | GEHC | Tax (F) | −1,929 | -$155.0K | EDGAR |
| 2023-03-16 | GEHC | Mixed | −5,684 | -$2.71M | EDGAR |
| 2023-03-03 | GEHC | Mixed | +4,116 | -$377.2K | EDGAR |
| 2023-02-03 | GEHC | Grant (A) | +4,910 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.